Lourdes Carbonell - Concepedia

Author

Lourdes Carbonell

Universitat de Barcelona

Also Known As

Carbonell, L., L Carbonell, L. CARBONELL, L. Carbonell, Lourdes Carbonell

Publications

443

Citations

H-Index

Concepts

All Affiliations

Universitat de Barcelona

About

Lourdes Carbonell is an author at Universitat de Barcelona specializing in neuropharmacology, medicine, and neurophysiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	67
2	Social Sciences	2	2	51
3	Neuroscience	2	2	51
4	Pharmacology	2	2	33
5	Endocrinology	1	1	16

Lourdes Carbonell

Publications

320

Citations

H-Index

Page 1

	Year	Citations
Polyamines inhibit lipid peroxidation in senescing oat leaves A. Borrell, Lourdes Carbonell, Rosa Farrás, Physiologia Plantarum	1997	110
Effect of Suckling on Plasma Prolactin and Hypothalamic Monoamine Levels in the Rat F. MENA, A Enjalbert, Lourdes Carbonell, Endocrinology	1976	87
Prolactin Inhibiting Activity of Dopamine-Free Subcellular Fractions from Rat Mediobasal Hypothalamus A Enjalbert, F. Moos, Lourdes Carbonell, Neuroendocrinology	1977	43
Caffeine improves attention deficit in neonatal 6-OHDA lesioned rats, an animal model of attention deficit hyperactivity disorder (ADHD) Miguel Caballero, Fabiana Núñez, S Ahern, Neuroscience Letters AdhdPsychiatryBehavioral NeuroscienceNeurophysiologyAnimal Model	2011	34
Demonstration of inhibition of cyclic AMP accumulation in brain by very low concentrations of lithium in the presence of α-adrenoceptor blockade Frederic Mármol, Lourdes Carbonell, Maria Laura Cuffí, European Journal of Pharmacology Molecular Pharmacology Social SciencesHyperpolarization (Biology)Electrolyte DisturbanceNeurochemistryNeuromodulation (Medicine)	1992	17
Effect of chronic lithium treatment on the turnover of α2-adrenoceptors after chemical inactivation in rats Lourdes Carbonell, J Forn European Neuropsychopharmacology Adrenal GlandSodium HomeostasisMedicinePhysiologyNeuropharmacology	2004	16
Targeting Striatal Metabotropic Glutamate Receptor Type 5 in Parkinson`s Disease: Bridging Molecular Studies and Clinical Trials Antonio Vallano, Víctor Fernández‐Dueñas, Gloria García-Negredo, CNS & Neurological Disorders - Drug Targets	2013	13

Page 1